BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


SEARCH JOBS










 Company News
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014 5:49:55 AM
AstraZeneca PLC (AZN) Presents Data From Phase 3 Studies Of Lesinurad In Combination With Allopurinol In Gout Patients At American College of Rheumatology 2014 Annual Meeting 11/17/2014 12:56:11 PM
Deal-Hungry Pfizer (PFE) Unlikely To Make Fresh Bid For AstraZeneca PLC (AZN) 11/14/2014 6:54:28 AM
AstraZeneca PLC (AZN) And Isis Pharmaceuticals, Inc. (ISIS) To Co-Develop Targeted Oligonucleotide Delivery Methods 11/13/2014 8:40:28 AM
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014 6:09:31 AM
Amgen (AMGN) And AstraZeneca PLC (AZN) Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 11/12/2014 6:08:18 AM
Amgen (AMGN) And AstraZeneca PLC (AZN)'s Psoriasis Drug Tops Johnson & Johnson (JNJ)'s Stelara In Phase 3 Study 11/12/2014 6:07:17 AM
AstraZeneca PLC (AZN) To Present New Data From Its Growing Inflammation And Autoimmunity Pipeline At American College of Rheumatology 2014 Annual Meeting 11/11/2014 12:11:26 PM
MDBio Foundation Receives $50,000 Grant From AstraZeneca PLC (AZN) And MedImmune (AZN) 11/10/2014 10:45:22 AM
Memo To Sanofi (SAN.PA): AstraZeneca PLC (AZN)’s CEO Says He’s Australian 11/6/2014 6:41:32 AM
12345678910...